Vaccine News and Research

Latest Vaccine News and Research

New frontiers in medicine: COVID-19 lessons push for multidisciplinary collaboration

Researchers highlight the need for multidisciplinary collaboration in medicine, especially in addressing transmissible illnesses, precision medicine, and data science, as learned from the COVID-19 pandemic.

28 May 2024

UNICEF delivers first R21/Matrix-M malaria vaccine doses to Central African Republic

UNICEF delivered over 43,000 doses of the R21/Matrix-M malaria vaccine by air to Bangui, Central African Republic, today, with more than 120,000 doses to follow in the next days.

25 May 2024

Inflation Reduction Act boosts shingles vaccine uptake by 46% for Medicare Part D recipients

Among the aims of the Inflation Reduction Act (IRA) is reducing health care costs for older adults by eliminating cost sharing for certain drugs and vaccines covered by Medicare Part D.

23 May 2024

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants.

23 May 2024

Clues from bird flu’s ground zero on dairy farms in the Texas Panhandle

In early February, dairy farmers in the Texas Panhandle began to notice sick cattle. The buzz soon reached Darren Turley, executive director of the Texas Association of Dairymen: "They said there is something moving from herd to herd."

23 May 2024

New study maps out long COVID patterns in England, showing who is most at risk

A study of 19 million adults in England reveals demographic and clinical patterns of long COVID, highlighting higher rates among women, middle-aged adults, and those with comorbidities, with vaccination linked to lower incidence.

22 May 2024

Review highlights the rapidly evolving landscape of hepatocellular carcinoma treatment

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms.

22 May 2024

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes from severe COVID-19 disease and other infectious diseases.

22 May 2024

Study shows safety of extended HPV testing intervals in cervical cancer screening

The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.

22 May 2024

4 ways vaccine skeptics mislead you on measles and more

Measles is on the rise in the United States. So far this year, the number of cases is about 17 times what it was, on average, during the same period in each of the four years before, according to the Centers for Disease Control and Prevention.

22 May 2024

Health experts call for tighter biosecurity measures to monitor avian influenza

Health experts are calling for tighter biosecurity measures in global poultry production, from farms to markets, to monitor bird flu (avian influenza) following its spread among 888 cases of human infection with the avian influenza virus, also known as H5N1, have been reported from 23 countries, of which 463 were fatal, according to the World Health Organization (WHO).

21 May 2024

New tool may help identify newborns at highest risk for developing RSV lower respiratory tract infection

On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, according to research published at the ATS 2024 International Conference.

21 May 2024

LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

Announcing a new article publication for Zoonoses journal. The global coronavirus disease 2019 (COVID-19) pandemic was caused by SARS-CoV-2.

20 May 2024

New dengue vaccine TAK-003 gains WHO prequalification for high-burden areas

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.

20 May 2024

Study reveals alarming rates of postpartum depression among mothers in six countries

Study published in BMC Public Health identified the prevalence, predictors, and coping strategies for postpartum depression (PPD) among mothers in six countries, highlighting significant variation across different cultural and demographic contexts.

19 May 2024

Breakthroughs in germline-targeting HIV vaccine design for broad protection

Scientists have made several advances in the design of a class of HIV vaccines that could offer broad protection against the virus, according to four new research papers published this week in Science, Science Translational Medicine, and Science Immunology.

17 May 2024

Study reveals positive impact of repeat COVID-19 vaccinations

Health-care workers received the first doses of the COVID-19 vaccine in December 2020.

17 May 2024

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

17 May 2024

UVA develops big data tool to combat childhood diarrhea

University of Virginia researchers are developing a flexible online tool for navigating information used in the fight to save children from deadly diarrheal diseases by identifying transmission hotspots and accelerating the deployment of treatments and new vaccines.

17 May 2024

Pre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%

Study estimates COVID-19 hospitalization and mortality rates in the US during the pre-vaccination period, revealing significant age and racial disparities in outcomes.

17 May 2024

Vaccine News and Research

Latest Vaccine News and Research

New frontiers in medicine: COVID-19 lessons push for multidisciplinary collaboration

UNICEF delivers first R21/Matrix-M malaria vaccine doses to Central African Republic

Inflation Reduction Act boosts shingles vaccine uptake by 46% for Medicare Part D recipients

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

Clues from bird flu’s ground zero on dairy farms in the Texas Panhandle

New study maps out long COVID patterns in England, showing who is most at risk

Review highlights the rapidly evolving landscape of hepatocellular carcinoma treatment

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

Study shows safety of extended HPV testing intervals in cervical cancer screening

4 ways vaccine skeptics mislead you on measles and more

Health experts call for tighter biosecurity measures to monitor avian influenza

New tool may help identify newborns at highest risk for developing RSV lower respiratory tract infection

LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

New dengue vaccine TAK-003 gains WHO prequalification for high-burden areas

Study reveals alarming rates of postpartum depression among mothers in six countries

Breakthroughs in germline-targeting HIV vaccine design for broad protection

Study reveals positive impact of repeat COVID-19 vaccinations

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

UVA develops big data tool to combat childhood diarrhea

Pre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Vaccine News and Research

Latest Vaccine News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in